Login
$GMED
$80.90 -$0.93 (1.14%) Close

$GMED 4/A SEC Filings

Filed On Filing
13 Jan 2026 Form 4/A: Kline Kyle, Senior Vice President, CFO

Exercised 4,896 Stock Option (Right to Buy Class A Common Stock)

06 Sep 2023 Form 4/A: DeFord John A, Director

Received 15,578 shares as a grant or award · Granted 15,000 Stock Option (Right to Buy Class A Common Stock)

06 Feb 2023 Form 4/A: Pfeil Keith W, SVP, Chief Financial Officer

Received 833 shares by exercise or conversion ($41.4K) · Sold 833 shares ($63.4K)

18 Dec 2020 Form 4/A: Demski David M, Director

Received 330,000 shares by exercise or conversion ($11.9M) · Sold 330,000 shares ($18.6M)

02 Mar 2015 Form 4/A: Paul David C, Director

Received 500,000 shares by conversion · Gave 500,000 shares as a gift · Received 3,000,000 shares by conversion · 1 more

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support